Moneycontrol PRO
HomeNewsTrendsHealthSocial distancing, wearing face masks need to be pushed with vigour as COVID-19 cases rise

Social distancing, wearing face masks need to be pushed with vigour as COVID-19 cases rise

As COVID-19 cases continue to rise in India, social distancing and practice of wearing a mask in public need to be enforced with vigour.

June 28, 2020 / 13:18 IST
Representative image

Confirmed COVID-19 cases in India have crossed the five lakh-mark. To be precise, India has so far reported 5.28 lakh cases of COVID-19, a disease caused by the novel coronavirus. This includes over 16,000 deaths, according to latest data from the Union Health Ministry.

There are only three countries, the United States, Brazil and Russia, that have reported more cases. At this growth rate, India is expected to cross Russia, which has reported 6.2 lakh cases, in a week's time.

The government is still differing on declaring the spread of the virus as community transmission. However, Goa Chief Minister Pramod Sawant has gone on record saying that community transmission has begun in his state.

The term ‘community transmission’ is used when it is difficult to trace a case back to a carrier or source.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemicWhy are cases increasing?

There could be several reasons. India's gradual easing of lockdown has meant tha more people are coming out for work and other activities. This could increase the rate of transmission. Millions of migrant workers have returned to their villages and towns, taking the infection to those places as well.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

All this has happened, in addition to increase in testing numbers. On June 27, the Centre reported having conducted 2.3 lakh tests in a day. Just about a week ago, the daily testing numbers were around 1.8 lakh.

According to COVID-19 tracker Worldometer, India is testing about 5,963 people per million. This is much lower than the figures in US (96,675), Brazil (13,766) and Russia (1.28 lakh) — countries that have higher number of reported cases than India.

We also need to remember that rise in COVID-19 cases will also lead to an increase in number of tests.

On the positive side, the recovery rate has surged with over three lakh patients having been cured and discharged. This has taken the recovery rate to around 58 percent.

Cases and deaths per million population continues to be low at 384 and 12, respectively.

The Indian drug regulator has approved two antiviral drugs — Remdesivir and Favipiravir — for restricted emergency use. Corticosteroid drug Dexamethasone is now part of the treatment protocol. These drugs are expected to improve clinical outcomes and reduce number of COVID-19 deaths in the coming months.

No room for complacency

Yet, millions of Indians seem to have not grasped the concept of social distancing and wearing face masks, besides maintaining personal hygiene. There is a need to deliver this message more forcibly. Wearing masks in public places has to be enforced with much more vigour.

To be sure, there are practical problems as well in implementing social distancing and personal hygiene. It is a tall order for millions of people living in slums to maintain social distancing and hygiene. There are many who do not have piped water facility or cannot afford soaps to wash hands.

Despite all these problems, Dharavi — considered one of Asia's largest slums — managed to contain or cut COVID-19’s transmission pace. The Brihanmumbai Municipal Corporation (BMC) has done a commendable job by roping in private general practitioners, conducting doing door-to-door screening, testing, quarantining high risk people, setting up medical infrastructure like oxygen beds and closing containment zones, and providing them with food and groceries. However, the BMC continues to struggle in replicating this model in other areas of Mumbai.

If Dharavi can do it, why can’t other cities?

Click here for Moneycontrol’s full coverage of the novel coronavirus pandemic
Viswanath Pilla
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: Jun 28, 2020 01:13 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347